Arumpac, Aileen A.

HRN: 19-38-35  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2022
CO-AMOXICLAV 625MG (TAB)
06/20/2022
06/27/2022
PO
625mg
BID X 7 Days
S/P VBAC; UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: